- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 42 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 7 residues within 4Å:- Chain A: R.69, R.117, H.129
- Chain B: F.31, E.32, N.33, M.34
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: R.69, R.70
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: K.253, G.256, I.257, Q.258
- Chain B: P.232
Ligand excluded by PLIPSO4.6: 6 residues within 4Å:- Chain A: R.45, S.46, C.47, G.48, H.94, R.102
Ligand excluded by PLIPSO4.7: 5 residues within 4Å:- Chain A: K.56, E.155, G.156, H.157, N.158
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain A: T.98, D.99
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain A: N.67, Q.147, S.150, I.151
Ligand excluded by PLIPSO4.10: 6 residues within 4Å:- Chain A: V.71, P.72, R.117, G.118, E.244, A.247
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain A: N.239, Y.242, W.246, V.271
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain A: N.158, F.160, S.161, L.163, Y.168
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain A: E.298, L.301, R.305
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain A: Y.198, Q.199
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain A: S.164, S.165
Ligand excluded by PLIPSO4.16: 7 residues within 4Å:- Chain A: L.184, F.188, M.262, F.278, V.282
- Ligands: GOL.19, 2KR.20
Ligand excluded by PLIPSO4.23: 7 residues within 4Å:- Chain B: R.69, R.117, H.129
- Chain C: F.31, E.32, N.33, M.34
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain B: R.69, R.70
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain B: K.253, G.256, I.257, Q.258
- Chain C: P.232
Ligand excluded by PLIPSO4.26: 6 residues within 4Å:- Chain B: R.45, S.46, C.47, G.48, H.94, R.102
Ligand excluded by PLIPSO4.27: 5 residues within 4Å:- Chain B: K.56, E.155, G.156, H.157, N.158
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain B: T.98, D.99
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain B: N.67, Q.147, S.150, I.151
Ligand excluded by PLIPSO4.30: 6 residues within 4Å:- Chain B: V.71, P.72, R.117, G.118, E.244, A.247
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain B: N.239, Y.242, W.246, V.271
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain B: N.158, F.160, S.161, L.163, Y.168
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain B: E.298, L.301, R.305
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain B: Y.198, Q.199
Ligand excluded by PLIPSO4.35: 2 residues within 4Å:- Chain B: S.164, S.165
Ligand excluded by PLIPSO4.36: 7 residues within 4Å:- Chain B: L.184, F.188, M.262, F.278, V.282
- Ligands: GOL.39, 2KR.40
Ligand excluded by PLIPSO4.43: 7 residues within 4Å:- Chain A: F.31, E.32, N.33, M.34
- Chain C: R.69, R.117, H.129
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain C: R.69, R.70
Ligand excluded by PLIPSO4.45: 5 residues within 4Å:- Chain A: P.232
- Chain C: K.253, G.256, I.257, Q.258
Ligand excluded by PLIPSO4.46: 6 residues within 4Å:- Chain C: R.45, S.46, C.47, G.48, H.94, R.102
Ligand excluded by PLIPSO4.47: 5 residues within 4Å:- Chain C: K.56, E.155, G.156, H.157, N.158
Ligand excluded by PLIPSO4.48: 2 residues within 4Å:- Chain C: T.98, D.99
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain C: N.67, Q.147, S.150, I.151
Ligand excluded by PLIPSO4.50: 6 residues within 4Å:- Chain C: V.71, P.72, R.117, G.118, E.244, A.247
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain C: N.239, Y.242, W.246, V.271
Ligand excluded by PLIPSO4.52: 5 residues within 4Å:- Chain C: N.158, F.160, S.161, L.163, Y.168
Ligand excluded by PLIPSO4.53: 3 residues within 4Å:- Chain C: E.298, L.301, R.305
Ligand excluded by PLIPSO4.54: 2 residues within 4Å:- Chain C: Y.198, Q.199
Ligand excluded by PLIPSO4.55: 2 residues within 4Å:- Chain C: S.164, S.165
Ligand excluded by PLIPSO4.56: 7 residues within 4Å:- Chain C: L.184, F.188, M.262, F.278, V.282
- Ligands: GOL.59, 2KR.60
Ligand excluded by PLIP- 9 x GOL: GLYCEROL(Non-functional Binders)
GOL.17: 7 residues within 4Å:- Chain A: R.16, E.20, H.25, F.26, D.27, L.230
- Chain C: K.254
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.16, A:E.20, A:D.27, A:D.27
GOL.18: 2 residues within 4Å:- Chain A: N.92, P.296
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.92
GOL.19: 5 residues within 4Å:- Chain A: I.260, P.261, M.262
- Ligands: SO4.16, 2KR.20
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:M.262
GOL.37: 7 residues within 4Å:- Chain A: K.254
- Chain B: R.16, E.20, H.25, F.26, D.27, L.230
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.16, B:E.20, B:D.27, B:D.27
GOL.38: 2 residues within 4Å:- Chain B: N.92, P.296
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.92
GOL.39: 5 residues within 4Å:- Chain B: I.260, P.261, M.262
- Ligands: SO4.36, 2KR.40
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:M.262
GOL.57: 7 residues within 4Å:- Chain B: K.254
- Chain C: R.16, E.20, H.25, F.26, D.27, L.230
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.16, C:E.20, C:D.27, C:D.27
GOL.58: 2 residues within 4Å:- Chain C: N.92, P.296
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.92
GOL.59: 5 residues within 4Å:- Chain C: I.260, P.261, M.262
- Ligands: SO4.56, 2KR.60
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:M.262
- 3 x 2KR: N-[4-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]-5-methylpyridin-2-amine(Non-covalent)
2KR.20: 15 residues within 4Å:- Chain A: L.184, S.226, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278
- Ligands: SO4.16, GOL.19
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:I.241, A:Y.242, A:F.245, A:P.261, A:M.262, A:K.267, A:E.270, A:F.278, A:F.278
- Hydrogen bonds: A:Y.242, A:Q.275
- Water bridges: A:G.274, A:F.278
- pi-Stacking: A:F.278
2KR.40: 15 residues within 4Å:- Chain B: L.184, S.226, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278
- Ligands: SO4.36, GOL.39
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:I.241, B:Y.242, B:F.245, B:P.261, B:M.262, B:K.267, B:E.270, B:F.278, B:F.278
- Hydrogen bonds: B:Q.275
- Water bridges: B:G.274, B:F.278
- pi-Stacking: B:F.278
2KR.60: 15 residues within 4Å:- Chain C: L.184, S.226, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278
- Ligands: SO4.56, GOL.59
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:I.241, C:Y.242, C:F.245, C:P.261, C:M.262, C:K.267, C:E.270, C:F.278, C:F.278
- Hydrogen bonds: C:Y.242, C:Q.275
- Water bridges: C:G.274, C:F.278
- pi-Stacking: C:F.278
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hu, E. et al., Discovery of Novel Imidazo[4,5-b]pyridines as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A). Acs Med.Chem.Lett. (2014)
- Release Date
- 2014-07-23
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 42 x SO4: SULFATE ION(Non-functional Binders)
- 9 x GOL: GLYCEROL(Non-functional Binders)
- 3 x 2KR: N-[4-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]-5-methylpyridin-2-amine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hu, E. et al., Discovery of Novel Imidazo[4,5-b]pyridines as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A). Acs Med.Chem.Lett. (2014)
- Release Date
- 2014-07-23
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B